Search results for: Precision Medicine
Filter search results
Join Us in Our 50th Anniversary Celebration!
7 February 2012
…1962, at the time when international emphasis on prescription medicine efficacy and safety was just beginning, OHE has made significant contributions in several fields since that time. A range of…
Can lessons from valuing health be useful in valuing development aid?
25 March 2012
…doesn’t, much as a randomised clinical trial does in medicine. Outcome measures could be used to compare changes in the whole population or in sectors over time, identifying when aid…
Join OHE for Its 50th Anniversary Annual Lecture with Sir Michael Rawlins
12 April 2012
…the “gold standard”, instead urging a more pragmatic approach. Sir Michael’s experience – as a clinician, chair of the Committee on Safety of Medicines, and chair of NICE — uniquely…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 May 2012
…practice and expected production cost, rather than assessments of value. The paper discusses how a value based pricing (VBP) framework for efficient use and pricing of medicines also might be…
HTAinSite: Recent Changes in the Database of NICE Decisions
7 June 2012
…about HTAinSite, in May 2010, the service has evolved in important ways. Added, for example, is the option of including the decisions of the Scottish Medicines Consortium (SMC) in the…
Around the World in HTAs: Kenya – Riding the Waves of Change
19 May 2025
…Subsequently, a HTA focal point within MoH was introduced to oversee and coordinate HTA institutionalisation activities (2020), the Medicines Affordability Pricing Advisory Committee (MAPAC) was tasked to promote access, availability,…
Spotlight on OHE: Opportunity Costs of NICE Decisions in Wales and HESG 2015
20 January 2015
…in the OHE research paper with the same title [OHE Research paper 14/02]. This presentation was part of the “Medicines Knowledge Base” series of lunchtime briefing seminars organised by…
OHE Occasional Paper Critiques the Claxton et al. £13,000 per QALY Estimate
24 February 2015
…life year (QALY) in the English NHS in 2008/09. NICE currently uses a cost per QALY threshold of £20,000 to £30,000 – and so recommends many medicines and other…
OHE Briefing on Incentives to Follow Best Practice in Health Care
27 February 2015
…medicines or other health technologies. These incentives include monetary and non-monetary rewards. In the first section of the Briefing, the authors report the results of a review of empirical…